Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
A hospital in Pittsburgh has become the latest medical center to join a ground-breaking Apple Watch trial in the US that's ...
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.
Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial fibrillation, allowing it to combine cardiac mapping sensors and therapy delivery ...
Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelectâ„¢ Pulsed Field Ablation System, which was FDA approved in December 2023 ...
The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval ... and maintaining normal sinus rhythm. Atrial Fibrillation (AF) is the most common sustained ...